Abstract: An optical path control member according to an embodiment comprises: a first substrate; a first electrode disposed on the first substrate; a second substrate disposed on the first substrate; a second electrode disposed below the second substrate; and a light conversion unit disposed between the first electrode and the second electrode, wherein: the light conversion unit includes a partition wall portion, an accommodation portion, and a base portion; a light converting material including a dispersion liquid, light converting particles, and a dispersing agent is arranged in the accommodation portion; and the dispersing agent includes a nonionic dispersing agent.

Abstract: The present disclosure relates to a lithium secondary battery comprising a positive electrode including a positive electrode active material, a negative electrode including a negative electrode active material, and a non-aqueous electrolyte. The non-aqueous electrolyte includes an organic solvent, a lithium salt, a coumarin-based compound represented by [Chemical Formula 1], and a halogen-substituted cyclic carbonate, and the positive electrode active material includes a lithium manganese-rich oxide represented by [Chemical Formula 2].

Abstract: The present disclosure relates to a non-aqueous electrolyte including an organic solvent, a lithium salt, and a coumarin-based compound represented by the following Chemical Formula 1 and a lithium secondary battery including the non-aqueous electrolyte: in Chemical Formula 1, R is a substituent including one or more elements selected from the group consisting of C, O, N, B, S, P, Si, and F, and n is an integer of 1 to 6.

Abstract: An electrolyte composition and a lithium secondary battery including the same are disclose herein. The electrolyte composition has improved high temperature safety. In some embodiments, the electrolyte composition includes an additive including a compound represented by Formula 1. Each R1 is independently a single bond, an alkylene group having 1 to 10 carbon atoms, or each R2 is independently a double or triple bond including 2 carbon atoms, each R3 is independently hydrogen or an alkyl group having 1 to 4 carbon atoms, and a is an integer of 1 to 10. The additive may reinforce an SEI layer on the surface of an electrode, thereby having advantages of improved storage and lifetime characteristics at a high temperature and a decreased amount of gas generated in the battery.

Abstract: An optical path control member according to an embodiment comprises an adhesive layer disposed between a second electrode and a light conversion part, wherein: the light conversion part includes a partition wall part and a reception part alternately arranged; the partition wall part includes a first area from the upper surface of the partition wall part up to 30 ?m in a direction toward the first substrate, a third area from the lower surface of the partition wall part up to 30 ?m in a direction toward the second substrate, and a second area provided between the first area and the third area; and Si measured by XPS in the first area corresponds to 2 at % or less.

Abstract: Disclosed is a natural language query processing apparatus comprising, a processor that receives a natural language query input by a user and generates a structured query based on the natural language query, wherein the processor, when generating the structured query based on the natural language query, generates the structured query using a natural language processing result for the natural language query, a schema relationship extracted based on a relationship between subdatabases in a database related to the natural language query, and a cross-attention result generated between the natural language processing result and the schema relationship.

Abstract: A protein transduction domain and a fusion compound, which are more efficient, are proposed. As a result of selecting and testing a number of candidate peptides, the present inventors found that a GK1 peptide comprising 18 amino acids and a modified sequence obtained by replacing, adding, or deleting some sequences are bonded to high-molecular-weight materials such as proteins based on the basic sequence of the peptide, thus enabling the high-molecular-weight materials to smoothly penetrate into living bodies, for example, cells, tissues, or blood. A fusion compound, oligonucleotide, or vector using the same may be applied as a pharmaceutical composition for preventing or treating diseases.

Abstract: An additive for a non-aqueous electrolyte, a non-aqueous electrolyte including the same, and a lithium secondary battery including the same are disclosed herein. The additive includes an ionic compound to form a coating film on an electrode surface, thereby preventing gas generation at high temperature, a cell open-circuit voltage (OCV) drop, and a decrease in capacity retention rate, which are caused by elution of metal ions from an electrode. The additive improves durability, performance, and high temperature safety of the battery.

Abstract: A lithium secondary battery is disclosed herein. The secondary battery has improved high temperature safety and may prevent generation of a large amount of gas under a high temperature condition, which prevents an increase in resistance and a decrease in capacity due to the elution of metal ions from an electrode by uniformly forming a coating film on an electrode surface during activation of the battery. A positive electrode active material of the battery includes a high concentration(s) of nickel and/or manganese and a non-aqueous electrolyte including an additive are used, which improves performance and high-temperature safety of the battery.

Abstract: An optical path control member according to an embodiment comprises: a first substrate; a first electrode disposed on the first substrate; a light conversion part disposed on the first electrode; a second substrate disposed on the first substrate; a second electrode disposed under the second substrate; and an adhesive layer disposed between the light conversion part and the second electrode, wherein the light conversion part comprises alternately disposed partition wall portions and accommodation portions, light transmittance of the accommodation portions changes according to voltage application, the upper surfaces of the partition wall portions are in contact with the adhesive layer, the light conversion part is formed of a photocurable resin, the photocurable resin comprises an oligomer, a monomer, a photopolymerization initiator, and an additive, and the additive comprises an antistatic agent in an amount of 1.5 wt % to 3.0 wt %.

Abstract: Disclosed is a method for producing kidney organoids including steps of: (1) differentiating stem cells into metanephric mesenchyme cells; (2) forming metanephric mesenchyme cell aggregates by culturing the metanephric mesenchyme cells; and (3) differentiating the metanephric mesenchyme cell aggregates into kidney organoids.

Abstract: Provided is a scanning micromirror including a reflective surface rotatable with respect to a rotation axis, a rim disposed on the outside of the reflective surface, a spring positioned on the rotation axis and connected to the reflective surface, and a connector connecting the reflective surface and the rim. The rim may include a first sub-rim disposed on one side and a second sub-rim disposed on the other side with respect to the spring.

Abstract: An embodiment of the present disclosure provides an extracellular matrix-based bioadhesive as an adhesive in the form of a composition including an extracellular matrix-containing hydrogel and a gelatin curing agent, wherein the extracellular matrix-containing hydrogel is gelatinized. Since the extracellular matrix-based bioadhesive according to an embodiment of the present disclosure has the same or similar rheological properties as gelatin, the bioadhesive has flowability at a temperature of 30° C. or higher and may be evenly and easily applied to a lesion site in the body. In addition, the extracellular matrix-based bioadhesive according to an embodiment of the present disclosure may adhere well to the lesion site because of a level of adhesive strength that is about 2 to 6 times higher than that of fibrin glue used as a commercial tissue adhesive.

Abstract: An optical path control member according to an embodiment comprises: a first substrate; a first electrode disposed on the upper part of the first substrate; a second substrate disposed on the first substrate; a second electrode disposed on the lower part of the second substrate; and an optical conversion unit disposed between the first electrode and the second electrode. The optical conversion unit includes partition wall portions and receiving portions that are alternately disposed. The receiving portions change optical transmittance in response to the application of voltage, and include a dispersion and optical conversion particles dispersed in the dispersion. The refractive index ratio of the partition wall portions and the receiving portions is 1:0.95 to 1:1.05.

Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.

Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.

Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.

Abstract: An optical path control member, according to one embodiment, comprises: a first substrate; a first electrode disposed on the upper surface of the first substrate; a second substrate disposed above the first substrate; a second electrode disposed on the lower surface of the second substrate; and a light conversion unit disposed between the first electrode and the second electrode, wherein the light conversion unit comprises a partition wall part and an accommodation part which are alternately arranged. The accommodation part: has a light transmittance that varies according to the application of a voltage; comprises a dispersion liquid and a plurality of light-absorbing particles dispersed in the dispersion liquid; and has at least one protrusion part arranged therein. The protrusion part: makes contact with the partition wall part; and is extendedly arranged in a direction different from the extending direction of the partition wall part.

Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.

Abstract: A modified extracellular matrix-based hydrogel according to an example of the present disclosure includes an extracellular matrix-denatured collagen conjugate formed by a Michael addition reaction between an extracellular matrix having an amine group and a denatured collagen into which an ethylenically unsaturated bond functional group is introduced. The modified extracellular matrix-based hydrogel according to the present disclosure exhibits enhanced mechanical properties (e.g., viscoelasticity) compared to the extracellular matrix hydrogel before modification. In addition, it shows a high cell viability when the bioink is prepared by encapsulating cells in a modified extracellular matrix-based hydrogel according to the present disclosure.